Lambkin R, Dimmock N J
Department of Biological Sciences, University of Warwick, Coventry, UK.
J Gen Virol. 1995 Apr;76 ( Pt 4):889-97. doi: 10.1099/0022-1317-76-4-889.
Nine rabbits were immunized with type A influenza virions and the epitope specificities of the secondary serum haemagglutination-inhibition (HI) antibody response were analysed with a panel of neutralizing monoclonal (MAb) antibody double escape mutants. Each of the latter was made by sequential selection using a MAb directed to an epitope of a discrete antigenic site, site A, site B or site D, of the haemagglutinin (HA). Thus the epitope reactivity of the escape mutants was represented as A+ B- D-, A- B+ D- and A- B- D+. The HI antibody response of all antisera was biased to the site B epitope. In 9/12 antisera, obtained from seven rabbits immunized with whole virions, the site B epitope was predominant, representing 65-82% of the total HI antibody. The restriction of HI antibody was unaffected by strain of rabbit, route of inoculation (intravenous or subcutaneous), use of Freund's adjuvant, and up to four immunizing injections. In 3/7 rabbits immunized with whole virus, there was a HI antibody response to the HC2 (site A) or HC10 (site D) epitope, but not both, of equal magnitude to the site B epitope. The HI antibody response in one of the rabbits (#40) became more biased to the site B epitope between the third and fourth immunizing doses. Two further rabbits were immunized with virions which had been partially digested with bromelain and then purified from free HA. Both of these made equal HI antibody responses to the site B epitope and the site D epitope, possibly because their remaining HA spikes were better exposed. Overall, these data demonstrate an unexpected degree of restriction in the production of biologically relevant antibody, such that some rabbits (e.g. #45) mount an HI antibody response which is essentially epitope-specific. Implications for epitope specificity of HI antibody stimulated by human influenza vaccines, and also for the generation of antigenic drift variants are discussed. The reason for the non-responsiveness of the immune system to the many other HI epitopes of the HA is not known.
用甲型流感病毒粒子对9只兔子进行免疫,并使用一组中和单克隆(MAb)抗体双逃逸突变体分析二次血清血凝抑制(HI)抗体反应的表位特异性。后者中的每一个都是通过使用针对血凝素(HA)离散抗原位点A、位点B或位点D的表位的单克隆抗体进行连续选择而产生的。因此,逃逸突变体的表位反应性表示为A + B - D -、A - B + D - 和A - B - D +。所有抗血清的HI抗体反应都偏向于位点B表位。在从7只接种全病毒粒子的兔子获得的12份抗血清中,有9份中位点B表位占主导,占总HI抗体的65 - 82%。HI抗体的这种偏向不受兔子品系、接种途径(静脉内或皮下)、弗氏佐剂的使用以及多达四次免疫注射的影响。在7只接种全病毒的兔子中,有3只对HA的HC2(位点A)或HC10(位点D)表位产生了HI抗体反应,但不是两者都有,其反应强度与位点B表位相当。其中一只兔子(#40)在第三次和第四次免疫剂量之间,其HI抗体反应对位点B表位的偏向性增加。另外两只兔子用经菠萝蛋白酶部分消化然后从游离HA中纯化的病毒粒子进行免疫。这两只兔子对位点B表位和位点D表位产生了相等的HI抗体反应,可能是因为它们剩余的HA刺突暴露得更好。总体而言,这些数据表明在产生生物学相关抗体方面存在意想不到的限制程度,以至于一些兔子(例如#45)产生的HI抗体反应基本上是表位特异性的。讨论了对人流感疫苗刺激的HI抗体表位特异性的影响,以及对抗原性漂移变体产生的影响。免疫系统对HA的许多其他HI表位无反应的原因尚不清楚。